Multiple myeloma (MM) is an incurable B-cell malignancy, but with the emergence of immunotherapy, a potential cure is hopeful.

The complexity of their molecular composition and the variability in clinical presentation make clinical diagnosis and treatment selection a serious...

Multiple myeloma (MM) is a cancer of plasma cells. Normal (NL) cells are considered to pass through a precancerous state, such as monoclonal...

A retrospective study involving review of 71 medical records of patients diagnosed with Hodgkin's Lymphoma between February 2012 and January 2016 was...

Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and...

To assess the prognostic value of C-Reactive Protein (CRP), at diagnosis and during follow-up, of patients with Hodgkin’s Lymphoma treated at the...

Preventive versus curative photobiomodulation for oral mucositis in patients with multiple myeloma undergoing hematopoietic stem cell transplantation...

Laboratory reflex testing strategy for the early identification of primary care patients with multiple myeloma.

Sarcopenia does not impact the outcome of patients with Multiple Mieloma consolidated with autologous Hematopoietic Stem Cell Transplantation.

Bravo chi trova mettono alla prova le tue capacità di osservazione e di intuito. Perché anche se è raro, lo puoi trovare. È il tuo turno. Mettiti alla...

FAD dal titolo “TOGETHER, THE STRENGTH OF MULTIDISCIPLINARITY IN ANDERSON FABRY’S DISEASE MANAGEMENT”